Stay updated with breaking news from Per Hansen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Since the start of the year Wall Street analysts and veterans have looked on bemused as a frenzy of retail trading has pumped up a string of so-called meme stocks.
(Bloomberg) -- Danish investors and analysts spent the morning trying to figure out why a tiny biotechnology company suddenly soared almost 1,400% during U.S. trading hours. Orphazyme A/S says it has no idea why its American depositary shares surged overnight.
Read more about Latest meme stock: Danish biotechnology company jumps almost 1,400% on Business Standard. Orphazyme A/S, which develops therapies to treat genetic disorders, says it has no idea why its American depositary shares surged overnight
Pandemic propels makeover at shipping giant Maersk Shipping group Maersk said on Tuesday it expects average returns on invested capital towards 2025 to be significantly above recent years, propelled by high demand for containers to meet a surge in consumer orders. The Danish company said it aims to bolster supply chain logistics for clients such as Puma and Walmart as it spurs a transformation that began before the pandemic. Maersk Chief Executive Soren Skou told investors at a Capital Markets Day he expects return on invested capital (ROIC) – a measure of how well a company uses its capita...
2/2/2021 * Q4 sales, EBIT miss expectations * Firm expects 2-6% sales growth this year * CFO sees return to growth in bioethanol market in Q2 (Adds share reaction, CFO comment, analyst comment, background) By Nikolaj Skydsgaard COPENHAGEN, Feb 2 (Reuters) - Novozymes shares fell 4% on Tuesday after the enzyme maker missed fourth-quarter sales and earnings expectations, but said it expected sales to bounce back in 2021. Sales were flat in 2020, short of the 5% annual growth target set out in 2019 for 2020 through 2022. The company expects organic sales to grow 2-6% in 2021. "Despite the prevai...